HB 2202 appropriates $300,000 annually from 2026-2029 to fund a dementia care telementoring program for Arizona healthcare providers. The program, administered by the Department of Health Services, will provide virtual mentoring sessions focused on dementia detection, diagnosis, and care management, with priority for rural and underserved communities. Grant recipients must offer case-based sessions, continuing education credits, and report participation data. The program expires December 31, 2029, after which the funding will no longer be available.
SB 1023 requires Arizona optometrists to conduct eye exams at least annually to assess both vision and eye health, following community medical standards. It allows optometrists to extend eyeglass prescription validity up to two years or shorten it based on individual patient factors like health risks or medical conditions. The bill directly affects optometrists by setting standardized exam frequency and prescription rules, while patients may experience changes in how often they need new prescriptions. This legislation standardizes eye care practices without mandating specific medical outcomes.
This Arizona bill (HB 2364) bans mailing, shipping, or delivering abortion-inducing drugs via courier, delivery, or mail services. It makes selling such drugs through these methods a class 5 felony (or class 4 for healthcare workers acting in their job), and receiving them this way a class 1 misdemeanor. The law specifically excludes drugs prescribed for non-abortion medical purposes. It defines "abortion-inducing drug" as any substance used for medication abortion.
HB 2917 establishes an Arizona firefighter cancer registry to track cancer diagnoses among firefighters. The registry collects specific data - including cancer type, diagnosis date, years of service, and occupational exposure - voluntarily from firefighters, fire departments, healthcare providers, and existing cancer databases. All personal information remains confidential and cannot be used to determine eligibility for workers' compensation, retirement, or insurance benefits. The state health department must analyze the aggregated data and submit annual reports to the governor and legislature starting in 2027, focusing on trends and prevention recommendations.
HB 2444 allows Arizona pharmacists to independently order, perform, and interpret certain FDA-waived tests (like flu, strep, or COVID-19 tests) and initiate treatment for specific conditions - including influenza, strep throat, HIV prevention, and other public health threats - without a physician's direct order. It directly affects pharmacists (who gain new clinical authority) and patients aged six or older who need treatment for those conditions. Key provisions require pharmacists to follow a statewide protocol covering documentation, referrals, patient screening, and evidence-based guidelines, while mandating notification to a patient’s primary care provider within 72 hours of treatment. The bill also prohibits pharmacists from prescribing opioids or treating minors without parental consent.
HB 2437 establishes Arizona’s participation in the Emergency Medical Services (EMS) Licensure Interstate Compact. It allows Arizona-licensed EMTs, AEMTs, and paramedics to practice temporarily in other participating states without obtaining new licenses, while ensuring public safety through standardized requirements. To maintain reciprocity, Arizona must require national registry exams (NREMT), have complaint investigation systems, conduct background checks for new licenses, and share adverse action information with the compact’s commission. This directly affects EMS personnel who work across state lines, including military members and their spouses transitioning to civilian roles. The bill creates a framework for mutual recognition but does not change Arizona’s existing licensure rules for in-state practice.
This bill gives residents in Arizona nursing care institutions and assisted living facilities (where care is partially or fully paid with public funds) the right to install electronic monitoring devices in their rooms for audio or video recording. Residents or their authorized representatives must submit a written notice and consent form to the facility before installation, detailing device type, recording preferences, and specific privacy settings. The form must specify when monitoring should be paused (e.g., during bathing, medical exams, or visits with family/attorneys) and who can access recordings. These requirements ensure residents can customize monitoring while maintaining facility operations.
HB 2188 establishes a state grant program to provide language acquisition services for infants and toddlers who are deaf or hard of hearing in Arizona. The program, administered by the state department, funds listening and spoken language services through contracted providers and requires referrals to both the grant program and the Arizona State Schools for the Deaf and the Blind for American Sign Language (ASL) and other language options. Families accessing early intervention services must be directed to these resources. The bill directly affects families with young children who are deaf or hard of hearing, aiming to expand access to language development support through specific service referrals and state-funded grants.
HB 2224 allocates $2 million annually from Arizona's state general fund starting in fiscal year 2026-2027 to the Department of Economic Security for its existing produce incentive program. The bill directly affects the Department of Economic Security, which administers the program, and would impact eligible Arizona residents who use the program's incentives to purchase fresh produce. The funding is exempt from standard appropriation lapsing rules, ensuring consistent annual support. This is a procedural budgetary measure, not a policy change, as it only provides funding for an already-established program.
HB 2697 allows pharmacists, health departments, and healthcare providers to dispense or distribute expired FDA-approved naloxone (an opioid overdose reversal medication) to individuals at risk of overdose, their families, or community organizations that assist them. The bill defines "expired opioid antagonist" as medication with an expiration date within five years of use, expanding access to this critical tool. It provides immunity from liability for professionals acting in good faith while following protocols, including instructing users to call emergency services after administration. This policy directly affects people at risk of opioid overdose, pharmacists, healthcare providers, and community health programs distributing naloxone.
